Patrick Bilbo is Chief Operating Officer of Organogenesis Holdings Inc.. Currently has a direct ownership of 809,082 shares of ORGO, which is worth approximately $2.58 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 2,497 shares (Class A Common Stock) at a price of $2.8 per share, resulting in proceeds of $6,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 809K
0% 3M change
61.06% 12M change
Total Value Held $2.58 Million

Patrick Bilbo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
SELL
Payment of exercise price or tax liability
$6,991 $2.8 p/Share
2,497 Reduced 0.31%
809,082 Class A Common Stock
Mar 28 2024
BUY
Exercise of conversion of derivative security
$179,655 $1.18 p/Share
152,250 Added 15.8%
811,579 Class A Common Stock
Feb 21 2024
BUY
Grant, award, or other acquisition
-
187,318 Added 22.12%
659,329 Class A Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$2,752 $3.48 p/Share
791 Reduced 0.17%
472,011 Class A Common Stock
Feb 15 2024
SELL
Payment of exercise price or tax liability
$108,681 $3.68 p/Share
29,533 Reduced 5.88%
472,802 Class A Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$5,704 $2.13 p/Share
2,678 Reduced 0.53%
502,335 Class A Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
327,386 Added 39.33%
505,013 Class A Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$2,574 $2.75 p/Share
936 Reduced 0.52%
177,627 Class A Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$13,429 $2.92 p/Share
4,599 Reduced 2.51%
178,563 Class A Common Stock
Apr 01 2022
SELL
Payment of exercise price or tax liability
$19,701 $7.89 p/Share
2,497 Reduced 1.34%
183,162 Class A Common Stock
Feb 16 2022
SELL
Payment of exercise price or tax liability
$7,290 $7.78 p/Share
937 Reduced 0.5%
185,659 Class A Common Stock
Feb 15 2022
BUY
Grant, award, or other acquisition
-
52,926 Added 22.1%
186,596 Class A Common Stock
Nov 10 2021
BUY
Exercise of conversion of derivative security
$43,848 $1.44 p/Share
30,450 Added 18.55%
133,670 Class A Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
$49,516 $19.83 p/Share
2,497 Reduced 1.5%
164,120 Class A Common Stock
Feb 16 2021
BUY
Grant, award, or other acquisition
-
10,782 Added 6.08%
166,617 Class A Common Stock
PB

Patrick Bilbo

Chief Operating Officer
Canton, MA

Track Institutional and Insider Activities on ORGO

Follow Organogenesis Holdings Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO